EPIDERMAL GROWTH FACTOR-MEDIATED ACTIVATION OF THE MAP KINASE CASCADE RESULTS IN ALTERED EXPRESSION AND FUNCTION OF ABCG2 (BCRP)

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Drug Metabolism And Disposition

• Publication date

  2006-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1124/dmd.105.007591PMID 16415123
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Breast cancer resistance protein: Molecular target for anticancer drug resistance and pharmacokinetics/pharmacodynamics

  2005cited by this paper
• The epidermal growth factor receptor as a target for colorectal cancer therapy.

  2005influential reference
• ABC transporters in the balance: is there a role in multidrug resistance?

  2005cited by this paper
• Expression Level of ABCG2 in the Placenta Decreases from the Mid Stage to the End of Gestation

  2005cited by this paper
• The breast cancer resistance protein BCRP (ABCG2) concentrates drugs and carcinogenic xenotoxins into milk

  2005cited by this paper
• VARIABLE EXPRESSION OF MRP2 (ABCC2) IN HUMAN PLACENTA: INFLUENCE OF GESTATIONAL AGE AND CELLULAR DIFFERENTIATION

  2005cited by this paper
• REGULATION OF THE CELL SURFACE EXPRESSION OF HUMAN BCRP/ABCG2 BY THE PHOSPHORYLATION STATE OF AKT IN POLARIZED CELLS

  2005influential reference
• Expression, localization, and function of MRP5 (ABCC5), a transporter for cyclic nucleotides, in human placenta and cultured human trophoblasts: effects of gestational age and cellular differentiation.

  2005influential reference
• The in vitro effects of triiodothyronine on epidermal growth factor-induced trophoblast function.

  2005cited by this paper
• Gefitinib ("Iressa", ZD1839), an epidermal growth factor receptor tyrosine kinase inhibitor, reverses breast cancer resistance protein/ABCG2-mediated drug resistance.

  2005cited by this paper
• Gefitinib reverses breast cancer resistance protein-mediated drug resistance.

  2004cited by this paper
• Folate Deprivation Results in the Loss of Breast Cancer Resistance Protein (BCRP/ABCG2) Expression

  2004cited by this paper
• The MRP-related and BCRP/ABCG2 multidrug resistance proteins: biology, substrate specificity and regulation.

  2004cited by this paper
• ABCG2 – a transporter for all seasons

  2004cited by this paper
• Characterization of Oligomeric Human Half-ABC Transporter ATP-binding Cassette G2*

  2004cited by this paper
• Adrenomedullin Is Decreased in Preeclampsia Because of Failed Response to Epidermal Growth Factor and Impaired Syncytialization

  2003cited by this paper
• ABCG2 Transports Sulfated Conjugates of Steroids and Xenobiotics*

  2003cited by this paper
• The central role of human chorionic gonadotropin in the formation of human placental syncytium.

  2003cited by this paper
• New aspects in placental drug transfer.

  2003cited by this paper
• Dominant‐negative inhibition of breast cancer resistance protein as drug efflux pump through the inhibition of S‐S dependent homodimerization

  2002cited by this paper
• Modulation of Trophoblast Cell Death by Oxygen and EGF

  2002cited by this paper
• The breast cancer resistance protein protects against a major chlorophyll-derived dietary phototoxin and protoporphyria

  2002cited by this paper
• From MDR to MXR: new understanding of multidrug resistance systems, their properties and clinical significance

  2001cited by this paper
• Acquired mutations in the MXR/BCRP/ABCP gene alter substrate specificity in MXR/BCRP/ABCP-overexpressing cells.

  2001cited by this paper
• A comprehensive two‐dimensional map of cytosolic proteins of Bacillus subtilis

  2001influential reference
• Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues.

  2001cited by this paper
• Activation of the EGF receptor signaling pathway in airway epithelial cells exposed to Utah Valley PM.

  2001cited by this paper
• Promoter characterization and genomic organization of the human breast cancer resistance protein (ATP-binding cassette transporter G2) gene.

  2001cited by this paper
• Role of breast cancer resistance protein in the bioavailability and fetal penetration of topotecan.

  2000cited by this paper
• Maternal Epidermal Growth Factor Deficiency Causes Fetal Hypoglycemia and Intrauterine Growth Retardation in Mice: Possible Involvement of Placental Glucose Transporter GLUT3 Expression1.

  1999cited by this paper
• Maternal epidermal growth factor deficiency causes fetal hypoglycemia and intrauterine growth retardation in mice: possible involvement of placental glucose transporter GLUT3 expression.

  1999cited by this paper
• A multidrug resistance transporter from human MCF-7 breast cancer cells.

  1998cited by this paper
• In vitro cultured human term cytotrophoblast: a model for normal primary epithelial cells demonstrating a spontaneous differentiation programme that requires EGF for extensive development of syncytium.

  1997influential reference
• Permeability properties of monolayers of the human trophoblast cell line BeWo.

  1997cited by this paper
• The proliferation of MAP kinase signaling pathways in yeast.

  1995cited by this paper
• Neither ERK nor JNK/SAPK MAP kinase subtypes are essential for histone H3/HMG-14 phosphorylation or c-fos and c-jun induction.

  1995cited by this paper
• Functional characterization of L-alanine transport in a placental choriocarcinoma cell line (BeWo).

  1994cited by this paper
• Differential activation of ERK and JNK mitogen-activated protein kinases by Raf-1 and MEKK.

  1994cited by this paper
• Immunohistochemical demonstration of epidermal growth factor (EGF) receptors in normal human placental villi.

  1990cited by this paper
• Isolation of pure villous cytotrophoblast from term human placenta using immunomagnetic microspheres.

  1989cited by this paper
• Induction of differentiated trophoblast function by epidermal growth factor: relation of immunohistochemically detected cellular epidermal growth factor receptor levels.

  1987cited by this paper
• Epidermal growth factor

  1972cited by this paper
• The establishment of a cell line of human hormone-synthesizing trophoblastic cells in vitro.

  1968cited by this paper

• Altered gene expression and activity of human placental drug-metabolizing cytochrome P450 enzymes across gestation.

  2026cites this paper
• Pretreatment of cancer cells with inhibitors of PKCδ, EGFR, and JNK increased intracellular hypericin content and enhanced the effectiveness of photodynamic therapy.

  2025cites this paper
• Linking TLR-7 Signaling to Downregulation of Placental P-Glycoprotein: Implications for Fetal Drug Exposure

  2025cites this paper
• Absolute Membrane Protein Abundance of P-gp, BCRP and MRPs in Term Human Placenta Tissue and Commonly Used Cell Systems: Application in PBPK Modeling of Placental Drug Disposition.

  2024cites this paper
• Enhancing of cerebral Abeta clearance by modulation of ABC transporter expression: a review of experimental approaches

  2024cites this paper
• Targeting breast cancer resistance protein (BCRP/ABCG2) in cancer

  2023cites this paper
• Changes in Expression and Function of Placental and Intestinal P-gp and BCRP Transporters during Pregnancy

  2023cites this paper
• ABCG2 Gene and ABCG2 Protein Expression in Colorectal Cancer—In Silico and Wet Analysis

  2023cites this paper
• The significance of ABC transporters in human placenta for the exposure of fetus to xenobiotics

  2022cites this paper
• Gestational Age Variation in Human Placental Drug Transporters

  2022cites this paper
• Protein Kinases and Cross-talk between Post-translational Modifications in the Regulation of Drug Transporters

  2022cites this paper
• Using empirical biological knowledge to infer regulatory networks from multi-omics data

  2022cites this paper
• Quantitative Comparison of Breast Cancer Resistance Protein (BCRP/ABCG2) Expression and Function Between Maternal Blood-Brain Barrier and Placental Barrier in Mice at Different Gestational Ages

  2022cites this paper
• Transporter Regulation in Critical Protective Barriers: Focus on Brain and Placenta

  2022cites this paper
• Regulation of Drug Transport Proteins—From Mechanisms to Clinical Impact: A White Paper on Behalf of the International Transporter Consortium

  2022cites this paper
• Pharmacokinetics and placental transfer of dolutegravir in pregnancy.

  2021cites this paper
• Multidrug efflux transporter ABCG2: expression and regulation

  2021cites this paper
• Low oxygen tension differentially regulates the expression of placental solute carriers and ABC transporters

  2020cites this paper
• Placenta-Specific Genes, Their Regulation During Villous Trophoblast Differentiation and Dysregulation in Preterm Preeclampsia

  2020cites this paper
• Repressing PDCD4 activates JNK/ABCG2 pathway to induce chemoresistance to fluorouracil in colorectal cancer cells

  2020cites this paper
• Gestational Age–Dependent Abundance of Human Placental Transporters as Determined by Quantitative Targeted Proteomics

  2020influential citation
• Biomarkers of Toxicity in Human Placenta

  2019cites this paper
• Transplacental transport of paracetamol and its phase II metabolites using the ex vivo placenta perfusion model

  2019cites this paper
• Mechanisms of Chemotherapy Resistance in Triple-Negative Breast Cancer—How We Can Rise to the Challenge

  2019cites this paper
• Amphiregulin promotes trophoblast invasion and increases MMP9/TIMP1 ratio through ERK1/2 and Akt signal pathways.

  2019cites this paper
• Contributions of Drug Transporters to Blood-Placental Barrier.

  2019cites this paper
• The Role of ATP-Binding Cassette Transporters in the Chemoresistance of Anaplastic Thyroid Cancer: A Systematic Review.

  2019cites this paper
• Quantification of ERK kinase activity in biological samples using differential sensing.

  2019cites this paper
• Equilibrative Nucleoside Transporter 1 (ENT1, SLC29A1) Facilitates Transfer of the Antiretroviral Drug Abacavir across the Placenta

  2018cites this paper
• Interindividual Regulation of the Breast Cancer Resistance Protein/ABCG2 Transporter in Term Human Placentas

  2018cites this paper
• Beyond Competitive Inhibition: Regulation of ABC Transporters by Kinases and Protein-Protein Interactions as Potential Mechanisms of Drug-Drug Interactions

  2018cites this paper
• Expression of Concentrative Nucleoside Transporters ( SLC28A) in the Human Placenta: Effects of Gestation Age and Prototype Differentiation-Affecting Agents.

  2018cites this paper
• Importance of the Keap1-Nrf2 pathway in NSCLC: Is it a possible biomarker?

  2018cites this paper
• An update on expression and function of P-gp/ABCB1 and BCRP/ABCG2 in the placenta and fetus

  2018cites this paper
• Placental transporter localization and expression in the Human: the importance of species, sex, and gestational age differences

  2017cites this paper
• Investigação do potencial terapêutico da doxazosina em modelos de gliomas in vitro e in vivo

  2017cites this paper
• Chapter 67 – The Significance of ABC Transporters in Human Placenta for the Exposure of Fetus to Xenobiotics

  2017cites this paper
• Cetuximab Prevents Methotrexate-Induced Cytotoxicity in Vitro through Epidermal Growth Factor Dependent Regulation of Renal Drug Transporters

  2017cites this paper
• Inhibition of CD147 expression promotes chemosensitivity in HNSCC cells by deactivating MAPK/ERK signaling pathway.

  2017cites this paper
• NFE2L2/NRF2 silencing-inducible miR-206 targets c-MET/EGFR and suppresses BCRP/ABCG2 in cancer cells

  2017cites this paper
• Hepatocyte-Specific Deletion of EGFR in Mice Reduces Hepatic Abcg2 Transport Activity Measured by [11C]erlotinib and Positron Emission Tomography

  2017cites this paper
• The xenoestrogens, bisphenol A and para-nonylphenol, decrease the expression of the ABCG2 transporter protein in human term placental explant cultures.

  2016cites this paper
• Expression levels of ABCG2 on cord red blood cells and study of fetal anemia associated with anti‐Jra

  2016cites this paper
• Nrf2 gene as a double-edged sword: Clinical relevance of its genetic polymorphisms

  2016cites this paper
• Effect of oral hypoglycaemic agents on placental ABC transporter expression and activity

  2016cites this paper
• Functional cyclic AMP response element in the breast cancer resistance protein (BCRP/ABCG2) promoter modulates epidermal growth factor receptor pathway- or androgen withdrawal-mediated BCRP/ABCG2 transcription in human cancer cells.

  2015cites this paper
• Regulation of drug transporter expression and function in the placenta

  2015cites this paper
• A New Strategy of ALA-Photodynamic Cancer Therapy: Inhibition of ABC Transporter ABCG2

  2015cites this paper
• Critical role of ABCG2 in ALA-photodynamic diagnosis and therapy of human brain tumor.

  2015cites this paper
• Megalin expression in human term and preterm placental villous tissues: effect of gestational age and sample processing and storage time.

  2015cites this paper
• Interplay of Breast Cancer Resistance Protein (BCRP) and Metabolizing Enzymes.

  2015cites this paper
• Effects of Bojungikkitang (a Polyherbal Formula), on Gefitinib Pharmacokinetics in Rats

  2015cites this paper
• Total bile acids in the maternal and fetal compartment in relation to placental ABCG2 expression in preeclamptic pregnancies complicated by HELLP syndrome.

  2015cites this paper
• In‐vitro evidence of enhanced breast cancer resistance protein‐mediated intestinal urate secretion by uremic toxins in Caco‐2 cells

  2015cites this paper
• Maternal-Fetal Disposition of Glyburide in Pregnant Mice Is Dependent on Gestational Age

  2014cites this paper
• Nuclear receptors in regulation of biotransformation enzymes and drug transporters in the placental barrier

  2014cites this paper
• ABCG2 regulated by MAPK pathways is associated with cancer progression in laryngeal squamous cell carcinoma.

  2014cites this paper
• Microsoft Word-85740523-file00.docx

  2014cites this paper
• Genetic polymorphism in the NRF2 gene as a prognosis marker for cancer chemotherapy

  2014cites this paper
• Genistein-Inhibited Cancer Stem Cell-Like Properties and Reduced Chemoresistance of Gastric Cancer

  2014cites this paper
• Structure and function of BCRP, a broad specificity transporter of xenobiotics and endobiotics

  2014cites this paper
• Epithelial-Mesenchymal Transition and Drug Resistance: Role, Molecular Mechanisms, and Therapeutic Strategies

  2014cites this paper
• Effect of oxygen on multidrug resistance in term human placenta.

  2014cites this paper
• The Multidrug-Resistance Transporter ABCB5 is Expressed in Human Placenta

  2014cites this paper
• Regulation of ABCG2 Expression in the Lactating Mammary Gland

  2014cites this paper
• Regulation of Placental Metabolism of Xenobiotics

  2014cites this paper
• Original Article ABCG2 regulated by MAPK pathways is associated with cancer progression in laryngeal squamous cell carcinoma

  2014cites this paper
• Drug Transport in the Placenta

  2014cites this paper
• 7-Ketocholesteryl-9-carboxynonanoate enhances the expression of ATP-binding cassette transporter A1 via CD36.

  2013cites this paper
• Molecularly-targeted anti-cancer drug interactions of the human ABCG2 multidrug transporter

  2013cites this paper
• Membranous ABCG2 expression in colorectal cancer independently correlates with shortened patient survival

  2013cites this paper
• SNP (–617C>A) in ARE-Like Loci of the NRF2 Gene: A New Biomarker for Prognosis of Lung Adenocarcinoma in Japanese Non-Smoking Women

  2013cites this paper
• Induction of Multidrug Resistance Transporter ABCG2 by Prolactin in Human Breast Cancer Cells

  2013cites this paper
• An overview of ABC and SLC drug transporter gene regulation.

  2013cites this paper
• In-situ generation of differential sensors that fingerprint kinases and the cellular response to their expression.

  2013cites this paper
• Role of Nrf2 in cancer photodynamic therapy: regulation of human ABC transporter ABCG2.

  2013cites this paper
• Developmental Expression, Function, and Regulation of Multidrug Resistance in the Mouse Placenta and Fetal Brain

  2012cites this paper
• Increased JNK1 Signaling Pathway Is Responsible for ABCG2-Mediated Multidrug Resistance in Human Colon Cancer

  2012cites this paper
• Cyclosporin A induces apoptosis in H9c2 cardiomyoblast cells through calcium-sensing receptor-mediated activation of the ERK MAPK and p38 MAPK pathways

  2012cites this paper
• The importance of HER2 signaling in the tumor-initiating cell population in aromatase inhibitor-resistant breast cancer

  2012cites this paper
• A Novel Epidermal Growth Factor-Dependent Extracellular Signal-Regulated MAP Kinase Cascade Involved in Sperm Functionality in Sheep1

  2012cites this paper
• ATP-Binding Cassette G-Subfamily Transporter 2 Regulates Cell Cycle Progression and Asymmetric Division in Mouse Cardiac Side Population Progenitor Cells

  2012cites this paper
• Pharmacotherapy in pregnancy; effect of ABC and SLC transporters on drug transport across the placenta and fetal drug exposure

  2012cites this paper
• Award Number: W81XWH-11-1-0775 TITLE: Investigating the Regulation and Potential Role of Nonhypoxic Hypoxia- Inducible Factor 1 (HIF-1) in Aromatase Inhibitor Resistant Breast Cancer

  2012cites this paper
• Investigating the Regulation and Potential Role of Nonhypoxic Hypoxia Inducible Factor 1 (HIF 1) in Aromatase Inhibitor Resistant Breast Cancer

  2012cites this paper
• Sphingolipid biosynthesis, metabolism and actions in placental trophoblast differentiation

  2012cites this paper
• Chinese a Nti鄄 Cancer a Ssociation

  2012cites this paper
• Fetoprotective activity of breast cancer resistance protein (BCRP, ABCG2): expression and function throughout pregnancy

  2011cites this paper
• S100A11, a dual growth regulator of epidermal keratinocytes

  2011cites this paper
• ATP-Binding Cassette Transporter Expression in Human Placenta as a Function of Pregnancy Condition

  2011cites this paper
• Placental expression of the heme transporter, feline leukemia virus subgroup C receptor, is related to maternal iron status in pregnant adolescents.

  2011cites this paper
• Genetic polymorphisms in placental transporters: implications for fetal drug exposure to oral antidiabetic agents

  2011cites this paper
• ATP-binding cassette efflux transporters in human placenta.

  2011cites this paper
• In vitro and in vivo evidence for the importance of breast cancer resistance protein transporters (BCRP/MXR/ABCP/ABCG2).

  2011cites this paper
• Role of Lapatinib and Retinoids In Overcoming Intrinsic Resistance to Hormonal Therapy In Breast Cancer

  2011cites this paper
• Contrasting effects of ERK on tight junction integrity in differentiated and under-differentiated Caco-2 cell monolayers.

  2011cites this paper
• The significance of ABC transporters in human placenta for the exposure of the fetus to xenobiotics

  2011cites this paper
• Pharmacogenetics of ATP-binding cassette transporters and clinical implications.

  2010cites this paper
• Placental P-glycoprotein and breast cancer resistance protein: influence of polymorphisms on fetal drug exposure and physiology.

  2010cites this paper
• Toxicokinetics of the food-toxin IQ in human placental perfusion is not affected by ABCG2 or xenobiotic metabolism.

  2010cites this paper